Citigroup
DMTX

Citigroup’s Dimension Therapeutics, Inc DMTX Stock Holding History

Citigroup’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1
Closed – – 7719
2017
Q2 		$0 Sell
1
-39
-98% -$53 ﹤0.01% 7730
2017
Q1 		$0 Sell
40
-12,270
-100% -$32.5K ﹤0.01% 7565
2016
Q4 		$54K Buy
12,310
+11,313
+1,135% +$60.2K ﹤0.01% 6111
2016
Q3 		$8K Sell
997
-244
-20% -$1.76K ﹤0.01% 6646
2016
Q2 		$7K Sell
1,241
-3,423
-73% -$26.1K ﹤0.01% 6708
2016
Q1 		$36K Buy
4,664
+2,973
+176% +$23.4K ﹤0.01% 6280
2015
Q4 		$19K Buy
+1,691
New +$21.4K ﹤0.01% 6522

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Citigroup's DMTX Position: Q3 2017 in Review

Citigroup sold out of Dimension Therapeutics, Inc (DMTX) in Q3 2017, closing a stake of 1 share.

Citigroup first reported a position in DMTX in Q4 2015 and held it in 7 quarters. The position peaked at $54K in Q4 2016. 34 funds tracked by Wall St. Rank hold DMTX as of Q3 2017.

  • Citigroup reported no remaining Dimension Therapeutics, Inc position as of Q3 2017 after selling out during the quarter.
  • Citigroup sold 1 Dimension Therapeutics, Inc share in Q3 2017.
  • Citigroup first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 7 quarters.
  • Citigroup's Dimension Therapeutics, Inc position peaked at $54K in Q4 2016.
  • 34 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q3 2017.

Based on Citigroup's 13F filing for Q3 2017, filed 13 Nov 2017.